Steven Cohen’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.67M Sell
16,673
-9,338
-36% -$931K ﹤0.01% 2513
2026
Q2
$2.46M Buy
+26,011
New +$2.61M ﹤0.01% 2249

Other funds holding INBX

Steven Cohen's INBX Position: Q3 2026 in Review

Steven Cohen reduced its Inhibrx (INBX) stake by 36% in Q3 2026, selling an estimated $931K and leaving 16,673 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

Steven Cohen first reported a position in INBX in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.46M in Q2 2026. 173 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Steven Cohen held 16,673 shares of Inhibrx worth $1.67M as of Q3 2026.
  • Steven Cohen sold 9,338 Inhibrx shares in Q3 2026, an estimated $931K.
  • Inhibrx made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2513 holding.
  • Steven Cohen first reported a position in Inhibrx in Q2 2026 and has held it in 2 quarters since.
  • Steven Cohen's Inhibrx position peaked at $2.46M in Q2 2026.
  • 173 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.